FY2025 Earnings Estimate for Zoetis Issued By William Blair

Zoetis Inc. (NYSE:ZTS) – Investment analysts at William Blair lifted their FY2025 earnings estimates for shares of Zoetis in a research report issued on Tuesday, August 5th. William Blair analyst B. Vazquez now forecasts that the company will post earnings per share of $6.34 for the year, up from their previous forecast of $6.26. The consensus estimate for Zoetis’ current full-year earnings is $6.07 per share. William Blair also issued estimates for Zoetis’ Q2 2026 earnings at $1.87 EPS and FY2026 earnings at $6.84 EPS.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The company had revenue of $2.46 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the previous year, the firm posted $1.56 EPS. The business’s revenue was up 4.2% compared to the same quarter last year.

Other research analysts also recently issued research reports about the stock. Piper Sandler boosted their price objective on shares of Zoetis from $205.00 to $210.00 and gave the stock an “overweight” rating in a report on Monday, May 12th. Stifel Nicolaus downgraded shares of Zoetis from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $165.00 to $160.00 in a report on Wednesday, June 18th. Leerink Partnrs downgraded shares of Zoetis from a “strong-buy” rating to a “hold” rating in a report on Thursday, July 17th. UBS Group dropped their price objective on shares of Zoetis from $189.00 to $170.00 and set a “neutral” rating on the stock in a report on Wednesday, May 7th. Finally, Leerink Partners cut shares of Zoetis from an “outperform” rating to a “market perform” rating and lowered their target price for the company from $180.00 to $155.00 in a research note on Thursday, July 17th. Four equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $204.63.

Zoetis Stock Performance

NYSE:ZTS opened at $148.11 on Thursday. The firm’s 50-day moving average is $157.14 and its 200-day moving average is $159.94. Zoetis has a 52-week low of $139.70 and a 52-week high of $200.33. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. The company has a market cap of $65.75 billion, a price-to-earnings ratio of 25.49, a PEG ratio of 2.41 and a beta of 0.88.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 3rd. Shareholders of record on Friday, July 18th will be given a $0.50 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.00 dividend on an annualized basis and a yield of 1.4%. Zoetis’s payout ratio is 34.42%.

Insider Buying and Selling

In other Zoetis news, EVP Roxanne Lagano sold 652 shares of the business’s stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $170.00, for a total value of $110,840.00. Following the transaction, the executive vice president directly owned 15,129 shares in the company, valued at $2,571,930. The trade was a 4.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.18% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Zoetis

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ZTS. Nova Wealth Management Inc. acquired a new position in Zoetis in the first quarter valued at about $25,000. 1248 Management LLC acquired a new position in Zoetis in the first quarter valued at about $27,000. Saudi Central Bank acquired a new position in Zoetis in the first quarter valued at about $29,000. Navigoe LLC acquired a new position in Zoetis in the fourth quarter valued at about $30,000. Finally, Cornerstone Planning Group LLC lifted its position in shares of Zoetis by 79.3% during the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company’s stock worth $30,000 after purchasing an additional 88 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.